Timothy M. Ryan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Timothy M. Ryan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Blaine Russell Roberts
Department of Biochemistry, Emory University School of Medicine, Atlanta, USA
2 shared publications - Amber Lothian
The Florey Institute of Neuroscience and Mental Health, The University of Melbourne Parkville, VIC, Australia
1 shared publication - Carolin Tumpach
Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne 3000, Australia
1 shared publication - Cathryn Louise Haigh
Division of Intramural Research, Laboratory of Neurological Infections and Immunity, National Institute of Allergy and Infectious Diseases, Rocky Mountain Laboratories, National Institutes of Health, Hamilton, USA
1 shared publication - Colin L. Masters
Florey Institute of Neuroscience and Mental Health
1 shared publication - Dominic James Hare
Elemental Bio-imaging Facility
1 shared publication
Latest Publications
- Open Access
- 11 April 2015
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 6 (1) , 60
The prion protein regulates beta-amyloid-mediated self-renewal of neural stem cells in vitro
The beta-amyloid (Aβ) peptide and the Aβ-oligomer receptor, prion protein (PrP), both influence neurogenesis. Using in vitro murine neural stem cells (NSCs), we investigated whether Aβ and PrP interact to modify neurogenesis. Aβ imparted PrP-dependent changes on NSC self-renewal, with PrP-ablated and wild-type NSCs displaying increased and decreased cell growth, respectively. In contrast, differentiation of Aβ-treated NSCs into mature cells was unaffected by PrP expression. Such marked PrP-dependent differences in NSC growth responses to Aβ provides further evidence of biologically significant interactions between these two factors and an important new insight into regulation of NSC self-renewal in vivo.
- 11 April 2015
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 6 (1) , 60
Open AccessThe prion protein regulates beta-amyloid-mediated self-renewal of neural stem cells in vitro
The beta-amyloid (Aβ) peptide and the Aβ-oligomer receptor, prion protein (PrP), both influence neurogenesis. Using in vitro murine neural stem cells (NSCs), we investigated whether Aβ and PrP interact to modify neurogenesis. Aβ imparted PrP-dependent changes on NSC self-renewal, with PrP-ablated and wild-type NSCs displaying increased and decreased cell growth, respectively. In contrast, differentiation of Aβ-treated NSCs into mature cells was unaffected by PrP expression. Such marked PrP-dependent differences in NSC growth responses to Aβ provides further evidence of biologically significant interactions between these two factors and an important new insight into regulation of NSC self-renewal in vivo.
- Open Access
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 5, 35
Metalloproteomics: principles, challenges and applications to neurodegeneration
Trace elements are required for a variety of normal biological functions. As our understanding of neurodegenerative disease advances we are identifying a number of metalloenzymes involved in disease process. Thus, the future of metals in neurobiology will rely more on detailed information regarding what metalloenzymes are present and how they are involved in the pathophysiology of disease. To gain this detailed information, we will rely less on bulk measures of the amount of a trace elements in a particular tissue and turn to metalloproteomic techniques to help elucidate both metalloprotein structure and function. Recent advances in metalloproteomics will translate to a richer understanding of the mechanism and precise role of metalloenzymes and proteins in the brain.
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 5, 35
Open AccessMetalloproteomics: principles, challenges and applications to neurodegeneration
Trace elements are required for a variety of normal biological functions. As our understanding of neurodegenerative disease advances we are identifying a number of metalloenzymes involved in disease process. Thus, the future of metals in neurobiology will rely more on detailed information regarding what metalloenzymes are present and how they are involved in the pathophysiology of disease. To gain this detailed information, we will rely less on bulk measures of the amount of a trace elements in a particular tissue and turn to metalloproteomic techniques to help elucidate both metalloprotein structure and function. Recent advances in metalloproteomics will translate to a richer understanding of the mechanism and precise role of metalloenzymes and proteins in the brain.